Clinical Trials on Acute Bacterial Skin and Skin Structure Infection

Total 61005 results

Melinta Therapeutics, LLC

Recruiting

Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous (IV) Oritavancin

Acute Bacterial Skin and Skin Structure Infection

United States, Spain, Greece, Portugal, Bulgaria, Latvia, Romania, Lithuania, Poland
Aziende Chimiche Riunite Angelini Francesco S.p.A
Hippocrates Research

Completed

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI (REDS)

Acute Bacterial Skin and Skin Structure Infection

Greece, Italy
Melinta Therapeutics, Inc.

Completed

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Acute Bacterial Skin and Skin Structure Infection

United States
The Medicines Company

Completed

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Acute Bacterial Skin and Skin Structure Infection

United States
Allergan

Completed

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Bacterial Infections | Acute Bacterial Skin and Skin Structure Infection

United States
Sonescence, Inc.
University of Southern California

Unknown

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

Non-healing Wound | Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
PolyMedix, Inc.

Completed

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA) | (Susceptible or Methicillin Resistant)

Canada, Russian Federation, Ukraine
Paratek Pharmaceuticals Inc

Withdrawn

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Skin Structures and Soft Tissue Infections
GlaxoSmithKline

Completed

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Infections, Bacterial

United States
Arpida AG

Completed

Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Complicated Skin and Skin Structure Infection

United States
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

Acute Bacterial Skin and Skin Structure Infections

United States, Bulgaria, Hungary, Ukraine
Arrevus Inc.

Completed

Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Acute Bacterial Skin and Skin Structure Infections

United States, Puerto Rico
Novexel Inc

Completed

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Acute Bacterial Skin and Skin Structure Infections

United States, Guatemala
MicuRx

Completed

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Bacterial Infections
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Acute Bacterial Skin and Skin Structure Infections

United States, Brazil, Bulgaria, Georgia, Germany, Guatemala, Latvia, Lithuania, Mexico, Poland, Russian Federation, South Africa, Turkey, Ukraine
Nabriva Therapeutics AG

Completed

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Bacterial Infections | Infection

United States
Wockhardt

Completed

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Acute Bacterial Skin and Skin Structure Infections

India
Bayer

Terminated

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study (DART)

Skin Disease, Infectious

Russian Federation, Mexico, Singapore
Trius Therapeutics LLC

Completed

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. (ABSSSI)

Skin and Subcutaneous Tissue Bacterial Infections

United States, Argentina, Brazil, Canada, Czechia, Germany, Hungary, Latvia, Peru, Slovakia, Ukraine
Allergan

Completed

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Acute Bacterial Skin and Skin Structure Infections

United States
AstraZeneca

Completed

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections (REACH)

Community Acquired Pneumonia (CAP) | Complicated Skin and Skin Structures Infections (cSSSI)

France, Italy, Spain, United Kingdom, Germany, Netherlands, Belgium, Portugal, Greece, Turkey
AbbVie

Completed

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Bacterial Infections | Staphylococcal Skin Infections | Methicillin-Resistant Staphylococcus Aureus

United States, Bulgaria, Chile, Colombia, Georgia, Greece, Guatemala, Latvia, Mexico, Panama, Spain, Ukraine
Forest Laboratories

Completed

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Bacterial Infection

United States
TenNor Therapeutics Inc.

Completed

Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Acute Bacterial Skin and Skin Structure Infection (ABSSSI) | Prosthetic Joints Infection (PJI)

China
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

Staphylococcal Skin Infections | Bacterial Skin Diseases | Skin Structure Infections

United States, Puerto Rico
Protez Pharmaceuticals, Inc.

Completed

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

Skin Infections

United States
Furiex Pharmaceuticals, Inc

Completed

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Complicated Skin and Skin Structure Infections

United States
Cubist Pharmaceuticals LLC

Terminated

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Soft Tissue Infections

United States
AstraZeneca

Withdrawn

Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis

Philippines
Paratek Pharmaceuticals Inc
Novartis Pharmaceuticals

Terminated

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) (CSSI)

Skin Diseases, Infectious

United States
Novartis

Terminated

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Staphylococcal Skin Infections

Italy
Melinta Therapeutics, Inc.

Completed

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Skin and Subcutaneous Tissue Bacterial Infections | Skin Structures and Soft Tissue Infections

United States, Argentina, Brazil, Bulgaria, Chile, Estonia, Georgia, Hungary, Korea, Republic of, Latvia, Mexico, Moldova, Republic of, Peru, Romania, Slovakia, Taiwan
Cubist Pharmaceuticals LLC

Terminated

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment (RENSE)

Renal Impairment | Complicated Skin and Skin Structure Infections | S. Aureus Bacteremia

United States
Pfizer

Completed

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Complicated Skin and Skin Structure Infections | Complicated Intra-abdominal Infections | Community-Acquired Bacterial Pneumonia

Korea, Republic of
Cumberland Pharmaceuticals

Completed

Telavancin Observational Use Registry (TOUR) (TOUR)

Complicated Skin and Skin Structure Infections | Hospital Acquired Bacterial Pneumonia | Ventilator Associated Bacterial Pneumonia | Gram Positive Infection

United States
Paratek Pharmaceuticals Inc

Completed

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Bacterial Infections | Skin Structures and Soft Tissue Infections

United States
Paratek Pharmaceuticals Inc

Completed

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Bacterial Infections | Skin Structures and Soft Tissue Infections

Croatia, Greece, Israel, Peru, South Africa, Turkey, United States, Bulgaria, Hungary, Latvia, Poland, Romania, Spain, Ukraine
SCARE (Study group for carbapenem resistance)

Unknown

Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients (DETERMINE)

Central Nervous System Infections | Pneumonia, Bacterial | Urinary Tract Infections | Intra-abdominal Infection | Osteomyelitis | Bloodstream Infection | Acute Bacterial Skin and Skin Structure Infection

Turkey
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Skin Diseases, Bacterial

Hong Kong, Korea, Republic of, United States, Philippines, Singapore, Canada, Thailand, Israel, Taiwan, Lebanon, Malaysia, South Africa
Arpida AG

Completed

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Skin Diseases, Bacterial

United States
Johnson & Johnson Pharmaceutical Research & Development...
PriCara, Unit of Ortho-McNeil, Inc.

Completed

A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections

Skin Diseases, Bacterial
Cubist Pharmaceuticals LLC

Terminated

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Complicated Skin or Skin Structure Infection

United States
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections

Streptococcal Infections | Abscess | Staphylococcal Skin Infections | Infectious Skin Diseases | Bacterial Skin Diseases

United States
Washington University School of Medicine

Completed

Individualized vs. Household MRSA Decolonization (HOME2DS)

Staphylococcal Skin Infection | Abscess | Furunculosis | Staphylococcus Aureus | MRSA Infection

United States
Aaron Chen
Johns Hopkins University; Thrasher Research Fund

Completed

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Staphylococcal Skin Infection | Abscess | Staphylococcal Infection | Folliculitis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Skin Infections, Bacterial

United States
GlaxoSmithKline

Completed

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Skin Infections, Bacterial

Netherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
Arrevus Inc.

Completed

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

Skin Diseases, Bacterial

United States
GlaxoSmithKline

Completed

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Skin Infections, Bacterial

United States
GlaxoSmithKline

Completed

Retapamulin Microdialysis Feasibility Study

Skin Infections, Bacterial

United States

Clinical Trials on Acute Bacterial Skin and Skin Structure Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations